{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T03:45:56Z","timestamp":1793677556220,"version":"4.5.1"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"31","license":[{"start":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T00:00:00Z","timestamp":1747526400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background and Aims<\/jats:title>\n                  <jats:p>Outpatient cardiology follow-up is the cornerstone of heart failure (HF) management, requiring adaptation based on patient severity. However, risk stratification using administrative data is scarce, and the association between follow-up and prognosis according to patient risk has yet to be described at a population level. This study aimed to describe prognosis and management across different strata using simple criteria, including diuretic use and prior HF hospitalization (HFH).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This nationwide cohort included all French patients reported as having HF in the previous 5 years and alive on 1 January 2020. Patients were categorized into four groups: (i) HFH within the past year (HFH \u2264 1y), (ii) HFH 1\u20135 years ago (HFH &amp;gt; 1y), (iii) not hospitalized using loop diuretics (NoHFH\/LD+), and (iv) not hospitalized without loop diuretics (NoHFH\/LD\u2212). Between-group associations, all-cause mortality (ACM), and cardiology follow-up were analysed using survival models.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The study included 655 919 patients [80 years (70\u201387), 48% female]. One-year ACM risk was 15.9%, ranging from 8.0% (NoHFH\/LD\u2212) to 25.0% (HFH \u2264 1y). Mortality risk was 1.61-fold higher for NoHFH\/LD+, 1.83-fold for HFH &amp;gt; 1y, and 2.32-fold for HFH \u2264 1y compared to NoHFH\/LD\u2212 (P &amp;lt; .0001). During the first year of follow-up (2020), cardiology consultation rates were similar across groups, with 40% of patients lacking an annual visit. Compared to no consultation, a single cardiology visit in the previous year (2019) was associated with a 6%\u20139% absolute reduction in 1-year ACM during the following year (2020) across all groups. The number needed to consult (NNC) to prevent one modelled death was 11\u201316. Additional visits showed greater benefit with increasing HF severity, with NNC ranging from 55 (NoHFH\/LD\u2212) to 20 (HFH \u2264 1y). The optimal follow-up to minimize the number of deaths without increasing the total number of consultations was 1 annual visit for NoHFH\/LD\u2212, 2\u20133 visits for NoHFH\/LD+ and HFH &amp;gt; 1y, and 4 visits for HFH \u2264 1y patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Despite having a HF diagnosis, 40% of patients do not see a cardiologist annually, regardless of disease severity. Simple stratification based on hospitalization history and diuretic use effectively predicts outcomes. Tailoring the annual number of HF consultations according to this stratification could optimize resource use and reduce avoidable modelled deaths.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehaf218","type":"journal-article","created":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T03:21:26Z","timestamp":1747538486000},"page":"3050-3065","source":"Crossref","is-referenced-by-count":32,"title":["Cardiologist follow-up and improved outcomes of heart failure: a French nationwide cohort"],"prefix":"10.1093","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9200-2729","authenticated-orcid":false,"given":"Guillaume","family":"Baudry","sequence":"first","affiliation":[{"name":"Centre d'Investigation Clinique Plurith\u00e9matique 1433, Universit\u00e9 de Lorraine, INSERM, Inserm U1116, CHRU de Nancy , 54000 Nancy ,","place":["France"]},{"name":"INI-CRCT (Cardiovascular and Renal Clinical Trialists) F-CRIN Network , Nancy ,","place":["France"]},{"name":"REICATRA, Universit\u00e9 de Lorraine , Vandoeuvre-les-Nancy ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6152-3065","authenticated-orcid":false,"given":"Ouarda","family":"Pereira","sequence":"additional","affiliation":[{"name":"Direction R\u00e9gionale du Service M\u00e9dical (DRSM) Grand Est , Strasbourg ,","place":["France"]},{"name":"D\u00e9partement des Maladies Chroniques, Caisse Nationale de l\u2019Assurance Maladie , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5288-9687","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Roubille","sequence":"additional","affiliation":[{"name":"PhyMedExp, Cardiology Department, University of Montpellier, INSERM U1046, CNRS UMR, 9214, INI-CRT , Montpellier ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3958-7572","authenticated-orcid":false,"given":"Marc","family":"Villaceque","sequence":"additional","affiliation":[{"name":"Cardio N\u00eemes Sud , N\u00eemes ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4058-3848","authenticated-orcid":false,"given":"Thibaud","family":"Damy","sequence":"additional","affiliation":[{"name":"Department of Cardiology, French Referral Center for Cardiac Amyloidosis, Henri Mondor University Hospital, Assistance-Publique H\u00f4pitaux de Paris (APHP) , 94000 Cr\u00e9teil ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0292-0498","authenticated-orcid":false,"given":"K\u00e9vin","family":"Duarte","sequence":"additional","affiliation":[{"name":"Centre d'Investigation Clinique Plurith\u00e9matique 1433, Universit\u00e9 de Lorraine, INSERM, Inserm U1116, CHRU de Nancy , 54000 Nancy ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9924-9075","authenticated-orcid":false,"given":"Philippe","family":"Tangre","sequence":"additional","affiliation":[{"name":"D\u00e9partement des Maladies Chroniques, Caisse Nationale de l\u2019Assurance Maladie , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3278-2057","authenticated-orcid":false,"given":"Nicolas","family":"Girerd","sequence":"additional","affiliation":[{"name":"Centre d'Investigation Clinique Plurith\u00e9matique 1433, Universit\u00e9 de Lorraine, INSERM, Inserm U1116, CHRU de Nancy , 54000 Nancy ,","place":["France"]},{"name":"INI-CRCT (Cardiovascular and Renal Clinical Trialists) F-CRIN Network , Nancy ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,5,18]]},"reference":[{"key":"2025101323020706000_ehaf218-B1","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.jacc.2013.11.053","article-title":"The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries","volume":"63","author":"Ambrosy","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2025101323020706000_ehaf218-B2","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology","volume":"118","author":"Savarese","year":"2023","journal-title":"Cardiovasc Res"},{"key":"2025101323020706000_ehaf218-B3","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2025101323020706000_ehaf218-B4","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.1093\/eurheartj\/ehae345","article-title":"Loop diuretic therapy with or without heart failure: impact on prognosis","volume":"45","author":"Friday","year":"2024","journal-title":"Eur Heart J"},{"key":"2025101323020706000_ehaf218-B5","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nrcardio.2015.14","article-title":"The vulnerable phase after hospitalization for heart failure","volume":"12","author":"Greene","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"2025101323020706000_ehaf218-B6","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1002\/ejhf.3103","article-title":"Risk of readmission and death after hospitalization for worsening heart failure: role of post-discharge follow-up visits in a real-world study from the Grand Est Region of France","volume":"26","author":"Baudry","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2025101323020706000_ehaf218-B7","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"key":"2025101323020706000_ehaf218-B8","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1136\/heartjnl-2022-321702","article-title":"Prevalence, outcomes and costs of a contemporary, multinational population with heart failure","volume":"109","author":"Norhammar","year":"2023","journal-title":"Heart"},{"key":"2025101323020706000_ehaf218-B9","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1136\/heartjnl-2021-320131","article-title":"Prevalence, incidence and survival of heart failure: a systematic review","volume":"108","author":"Emmons-Bell","year":"2022","journal-title":"Heart"},{"key":"2025101323020706000_ehaf218-B10","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/eurheartj\/ehac651","article-title":"Epidemiology of heart failure in young adults: a French nationwide cohort study","volume":"44","author":"Lecoeur","year":"2023","journal-title":"Eur Heart J"},{"key":"2025101323020706000_ehaf218-B11","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1001\/jamacardio.2024.0615","article-title":"Reversals in the decline of heart failure mortality in the US, 1999 to 2021","volume":"9","author":"Sayed","year":"2024","journal-title":"JAMA Cardiol"},{"key":"2025101323020706000_ehaf218-B12","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s40273-020-00952-0","article-title":"A systematic review of medical costs associated with heart failure in the USA (2014-2020)","volume":"38","author":"Urbich","year":"2020","journal-title":"Pharmacoeconomics"},{"key":"2025101323020706000_ehaf218-B13","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/ejhf.566","article-title":"European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions","volume":"18","author":"Crespo-Leiro","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2025101323020706000_ehaf218-B14","author":"Haute Autorit\u00e9 de Sant\u00e9"},{"key":"2025101323020706000_ehaf218-B15","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"2025101323020706000_ehaf218-B16","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/S0140-6736(22)02076-1","article-title":"Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial","volume":"400","author":"Mebazaa","year":"2022","journal-title":"Lancet"},{"key":"2025101323020706000_ehaf218-B17","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1002\/ejhf.2271","article-title":"Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: a multinational observational study (US, UK and Sweden)","volume":"23","author":"Savarese","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2025101323020706000_ehaf218-B18","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1002\/ejhf.1236","article-title":"Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology","volume":"20","author":"Crespo-Leiro","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2025101323020706000_ehaf218-B19","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/ki.2013.243","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"84","author":"Eknoyan","year":"2013","journal-title":"Kidney Int"},{"key":"2025101323020706000_ehaf218-B20","author":"European Society of Cardiology"},{"key":"2025101323020706000_ehaf218-B21","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s10557-016-6697-7","article-title":"Cardiac dysfunction, congestion and loop diuretics: their relationship to prognosis in heart failure","volume":"30","author":"Pellicori","year":"2016","journal-title":"Cardiovasc Drugs Ther"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/46\/31\/3050\/63105548\/ehaf218.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/46\/31\/3050\/63105548\/ehaf218.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T03:02:47Z","timestamp":1760410967000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/46\/31\/3050\/8126812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,18]]},"references-count":21,"journal-issue":{"issue":"31","published-online":{"date-parts":[[2025,5,18]]},"published-print":{"date-parts":[[2025,8,14]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehaf218","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8,14]]},"published":{"date-parts":[[2025,5,18]]}}}